Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor
Journal of Child and Adolescent Psychopharmacology January 6, 2025 Isabella Sutherland, Ming‐fen Ho, Paul E. Croarkin 10 citations
Interest in psychedelic therapies for adults is growing, with substances like MDMA for PTSD, psilocybin for treatment-resistant depression, and LSD for generalized anxiety disorder showing promise. However, research on these therapies in children and adolescents is limited, with no recent trials. Adolescents may still experiment with these substances recreationally or therapeutically as accessibility increases, raising significant concerns due to their vulnerability. The authors advocate for structured, safe, and well-controlled exploration of psychedelic therapies in adolescents.